Coya Therapeutics Inc
NASDAQ:COYA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Coya Therapeutics Inc
NASDAQ:COYA
|
US |
|
I
|
International Flavors & Fragrances Inc
XBER:IFF
|
US |
|
P
|
Proximus NV
F:BX7
|
BE |
|
C
|
CONSOL Energy Inc
F:C9X
|
US |
|
FirstEnergy Corp
NYSE:FE
|
US |
|
Vortex Energy Corp
F:AA3I
|
CA |
|
Bel Fuse Inc
F:BF2B
|
US |
|
Goldman Sachs Group Inc
NYSE:GS
|
US |
|
Minerals Technologies Inc
NYSE:MTX
|
US |
|
G
|
Geely Automobile Holdings Ltd
F:GRU
|
HK |
|
Innospec Inc
NASDAQ:IOSP
|
US |
|
King Copper Discovery Corp
F:3RI0
|
CA |
|
V
|
Veolia Environnement SA
SWB:VVD
|
FR |
|
M
|
MM Forgings Ltd
BSE:522241
|
IN |
|
Sovereign Metals Ltd
ASX:SVM
|
AU |
|
F
|
First Commonwealth Financial Corp
F:FCF
|
US |
|
PLDT Inc
NYSE:PHI
|
PH |
Wall St Price Targets
COYA Price Targets Summary
Coya Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for COYA is 16.07 USD with a low forecast of 14.14 USD and a high forecast of 18.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is COYA's stock price target?
Price Target
16.07
USD
According to Wall Street analysts, the average 1-year price target for COYA is 16.07 USD with a low forecast of 14.14 USD and a high forecast of 18.9 USD.
What is the Revenue forecast for Coya Therapeutics Inc?
Projected CAGR
-34%
The compound annual growth rate for Revenue over the next 5 years is -34%.